UPDATE: Jazz Pharmaceuticals acquires GW Pharma for $ 7.2 billion in cash and shares, GW rises 46% in the premarket
Pfizer and BioNTech, increasing the scale for coronavirus 2B vaccine doses, temporarily cut deliveries in the EU, Canada